Adaptive Focused Acoustics™ (AFA) technology offers a breakthrough alternative to traditional methods of Liposome preparation, by forming monodisperse liposomes at 4°C (below the lipid phase transition temperature) and eliminating the need to use organic solvents. Our AFA® technology also allows the construction of tightly distributed nanoemulsions achieving average mean particle sizes as low as 20nm.
- AFA-Liposome™ M220 130 µL Phospholipon 90G
- AFA-Liposome™ 2 mL SST Doxil Blank
- AFA-Liposome™ 2 mL DOPE
- AFA-Liposome™ 2 mL HEL
- AFA-Liposome™ 2 mL Phospholipon 90G
Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.